Anthropic’s IPO roadshow tests a less-than-decade AI cure claim
Anthropic CEO Dario Amodei says AI could make cancer, Alzheimer's, heart disease and mental illness relics of the past within a decade. Doctors reject the timetable ahead of an IPO.
Topic
Topic
Anthropic CEO Dario Amodei says AI could make cancer, Alzheimer's, heart disease and mental illness relics of the past within a decade. Doctors reject the timetable ahead of an IPO.
Anthropic's seven co-founders will each sell 3,378,378 shares in its IPO, netting about $250 million apiece at the $74 mid-range…
Anthropic targets a $1.5–2 trillion November IPO while asking job candidates what they would do if the stock fell to zero. Base p…
Anthropic's IPO could value the Claude maker at $2 trillion — the largest ever — turning its seven ex-OpenAI founders into billio…
Anthropic's seven cofounders pledged 80% of their stakes — about $79.4 billion — in the S-1 filed ahead of an IPO that could valu…
Anthropic's S-1 shows each of its seven co-founders holding roughly 240 million shares worth up to $14.4 billion — and an 80% giv…
Dario Amodei says up to 40% of his time goes to culture at Anthropic, which just reported $16.8 billion in Q3 revenue ahead of a…
Anthropic's IPO prospectus warns of 'catastrophic or existential risks to humanity' as the company prepares a potential $2tn flot…
A White House memo, an SNL parody and a dinner with Trump: Anthropic CEO Dario Amodei is now the public face of AI doomerism, squ…
Anthropic CEO Dario Amodei will dine with President Trump at the White House tonight, their first one-on-one meeting, Axios repor…
Anthropic CEO Dario Amodei discussed the pros and cons of taking the AI startup public in a Bloomberg interview, offering a rare…